Anavex Life Sciences annual free cash flow
2010
2011
2012
2013
2014
Anavex Life Sciences Free Cash Flow (FCF) History (AVXL)
Anavex Life Sciences reported −$2.7M in free cash flow for fiscal 2014, a decrease of $1.9M from the previous fiscal year.
View full Anavex Life Sciences company overviewAnavex Life Sciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2014 | 2014-09-30 | −$2.7M | −$1.9M | — | — |
| 2013 | 2013-09-30 | −$777,573 | $915,367 | — | — |
| 2012 | 2012-09-30 | −$1.7M | $2.1M | — | — |
| 2011 | 2011-09-30 | −$3.8M | $795,419 | — | — |
| 2010 | 2010-09-30 | −$4.6M | — | — | — |
Anavex Life Sciences quarterly free cash flow
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2015 | 2015-06-30 | −$1.4M | −$470,291 | — | — |
| Q2 2015 | 2015-03-31 | −$670,281 | −$322,752 | — | — |
| Q1 2015 | 2014-12-31 | −$693,070 | −$255,753 | — | — |
| Q4 2014 | 2014-09-30 | −$917,543 | −$433,035 | — | — |
| Q3 2014 | 2014-06-30 | −$960,005 | −$927,815 | — | — |
| Q2 2014 | 2014-03-31 | −$347,529 | −$218,227 | — | — |
| Q1 2014 | 2013-12-31 | −$437,317 | −$305,744 | — | — |
| Q4 2013 | 2013-09-30 | −$484,508 | −$232,575 | — | — |
| Q3 2013 | 2013-06-30 | −$32,190 | $206,512 | — | — |
| Q2 2013 | 2013-03-31 | −$129,302 | −$15,120 | — | — |
| Q1 2013 | 2012-12-31 | −$131,573 | $956,550 | — | — |
| Q4 2012 | 2012-09-30 | −$251,933 | $670,656 | — | — |
| Q3 2012 | 2012-06-30 | −$238,702 | $967,285 | — | — |
| Q2 2012 | 2012-03-31 | −$114,182 | $474,760 | — | — |
| Q1 2012 | 2011-12-31 | −$1.1M | −$4,162 | — | — |
| Q4 2011 | 2011-09-30 | −$922,589 | — | — | — |
| Q3 2011 | 2011-06-30 | −$1.2M | — | — | — |
| Q2 2011 | 2011-03-31 | −$588,942 | — | — | — |
| Q1 2011 | 2010-12-31 | −$1.1M | — | — | — |
Anavex Life Sciences free cash flow growth trends
Anavex Life Sciences's latest reported quarter, Q3 2015, generated −$1.4M in free cash flow, a decrease of $470,291 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Anavex Life Sciences filings at SEC.gov ↗